| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.28 | 0.04 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.26 | 0.08 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |